10x Genomics Inc (0A88)
LSE
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current 0A88 market cap is 0. The company's latest EPS is USD -2.4493 and P/E is -5.43.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 245.89M | 298.85M | 491.15M | 516.41M | 618.73M |
| Operating Income | -30.57M | -534.14M | -52.25M | -167.94M | -260.43M |
| Net Income | -31.25M | -542.73M | -58.22M | -166M | -255.1M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 605.92M | 929.34M | 1.02B | 1.03B | 965.14M |
| Total Liabilities | 185.84M | 190.27M | 201.26M | 223.24M | 224.1M |
| Total Equity | 420.08M | 739.07M | 817.57M | 805.74M | 741.04M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 34.63M | -217.9M | -21.37M | -33.61M | -15.2M |
| Investing | -42.77M | -38.39M | -106.73M | -350.89M | 133.49M |
| Financing | 414.59M | 468.91M | 35.3M | 15.82M | 13.67M |
| Market Cap | 0 |
| Price to Earnings Ratio | -5.43 |
| Price to Sales Ratio | 2.24 |
| Price to Cash Ratio | 3.85 |
| Price to Book Ratio | 1.87 |
| Dividend Yield | - |
| Shares Outstanding | 104.15M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0 (0%) |
| Company Name | 10x Genomics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.10xgenomics.com |
| Industry | lab analytical instruments (3826) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
